News Reduction of share capital Staff April 20, 2022 Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital Post Navigation Previous Clover’s Efficacy Data in Previously-Infected Individuals is Published in Lancet Infectious DiseaseNext Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss More Stories News Patient Care Casect Launches AI-Enhanced Case Log Platform for Surgeons Staff December 25, 2024 News CorVel Announces Effectiveness of Three-For-One Forward Stock Split Staff December 25, 2024 Cancer Clinical Trial DNA Melanoma News Pharmaceutical Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca Staff December 25, 2024
